StockDuty ← Dashboard Sep 01, 2026 06:24 AM ET
SignalFDA/Bio

NOVARTIS HALTS AUTOIMMUNE CAR-T TRIALS FOLLOWING THREE PATIENT DEATHS: WSJ - SEEKINGALPHA

Safety halt after three deaths signals major clinical setback for autoimmune CAR-T.

What changed
Why it matters
Safety halt after three deaths signals major clinical setback for autoimmune CAR-T.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →